Cargando…

Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction

BACKGROUND: To determine whether deep dry needling (DDN) of trigger points (TPs) in the lateral pterygoid muscle (LPM) would significantly reduce pain and improve function, compared with methocarbamol/paracetamol medication. MATERIAL AND METHODS: Forty-eight patients with chronic myofascial pain loc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Perez, Luis-Miguel, Infante-Cossio, Pedro, Granados-Nunez, Mercedes, Urresti-Lopez, Francisco-Javier, Lopez-Martos, Ricardo, Ruiz-Canela-Mendez, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464920/
https://www.ncbi.nlm.nih.gov/pubmed/25662558
http://dx.doi.org/10.4317/medoral.20384
_version_ 1782376049151049728
author Gonzalez-Perez, Luis-Miguel
Infante-Cossio, Pedro
Granados-Nunez, Mercedes
Urresti-Lopez, Francisco-Javier
Lopez-Martos, Ricardo
Ruiz-Canela-Mendez, Pablo
author_facet Gonzalez-Perez, Luis-Miguel
Infante-Cossio, Pedro
Granados-Nunez, Mercedes
Urresti-Lopez, Francisco-Javier
Lopez-Martos, Ricardo
Ruiz-Canela-Mendez, Pablo
author_sort Gonzalez-Perez, Luis-Miguel
collection PubMed
description BACKGROUND: To determine whether deep dry needling (DDN) of trigger points (TPs) in the lateral pterygoid muscle (LPM) would significantly reduce pain and improve function, compared with methocarbamol/paracetamol medication. MATERIAL AND METHODS: Forty-eight patients with chronic myofascial pain located in the LPM were selected and randomly assigned to one of two groups (DDN test group, n=24; drug-treated control group, n=24). The test group received three applications of needling of the LPM once per week for three weeks, while control group patients were given two tablets of a methocarbamol/paracetamol combination every six hours for three weeks. Assessments were carried out pretreatment, 2 and 8 weeks after finishing the treatment. RESULTS: A statistically significant difference (p<0.05) was detected for both groups with respect to pain reduction at rest and with mastication, but the DDN test group had significantly better levels of pain reduction. Moreover, statistically significant differences (p<0.05) up to day 70 in the test group were seen with respect to maximum mouth opening, laterality and protrusion movements compared with pretreatment values. Pain reduction in the test group was greater as a function of pain intensity at baseline. The evaluation of efficacy as assessed both by patients/investigators was better for the test group. 41% of the patients receiving the combination drug treatment described unpleasant side effects (mostly drowsiness). CONCLUSIONS: DDN of TPs in the LPM showed better efficacy in reducing pain and improving maximum mouth opening, laterality, and protrusion movements compared with methocarbamol/paracetamol treatment. No adverse events were observed with respect to DDN. Key words: Myofascial pain syndrome, myofascial trigger points, deep dry needling, lateral pterygoid muscle, randomized controlled trial, temporomandibular disorders.
format Online
Article
Text
id pubmed-4464920
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-44649202015-06-16 Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction Gonzalez-Perez, Luis-Miguel Infante-Cossio, Pedro Granados-Nunez, Mercedes Urresti-Lopez, Francisco-Javier Lopez-Martos, Ricardo Ruiz-Canela-Mendez, Pablo Med Oral Patol Oral Cir Bucal Research BACKGROUND: To determine whether deep dry needling (DDN) of trigger points (TPs) in the lateral pterygoid muscle (LPM) would significantly reduce pain and improve function, compared with methocarbamol/paracetamol medication. MATERIAL AND METHODS: Forty-eight patients with chronic myofascial pain located in the LPM were selected and randomly assigned to one of two groups (DDN test group, n=24; drug-treated control group, n=24). The test group received three applications of needling of the LPM once per week for three weeks, while control group patients were given two tablets of a methocarbamol/paracetamol combination every six hours for three weeks. Assessments were carried out pretreatment, 2 and 8 weeks after finishing the treatment. RESULTS: A statistically significant difference (p<0.05) was detected for both groups with respect to pain reduction at rest and with mastication, but the DDN test group had significantly better levels of pain reduction. Moreover, statistically significant differences (p<0.05) up to day 70 in the test group were seen with respect to maximum mouth opening, laterality and protrusion movements compared with pretreatment values. Pain reduction in the test group was greater as a function of pain intensity at baseline. The evaluation of efficacy as assessed both by patients/investigators was better for the test group. 41% of the patients receiving the combination drug treatment described unpleasant side effects (mostly drowsiness). CONCLUSIONS: DDN of TPs in the LPM showed better efficacy in reducing pain and improving maximum mouth opening, laterality, and protrusion movements compared with methocarbamol/paracetamol treatment. No adverse events were observed with respect to DDN. Key words: Myofascial pain syndrome, myofascial trigger points, deep dry needling, lateral pterygoid muscle, randomized controlled trial, temporomandibular disorders. Medicina Oral S.L. 2015-05 2015-02-07 /pmc/articles/PMC4464920/ /pubmed/25662558 http://dx.doi.org/10.4317/medoral.20384 Text en Copyright: © 2015 Medicina Oral S.L. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Gonzalez-Perez, Luis-Miguel
Infante-Cossio, Pedro
Granados-Nunez, Mercedes
Urresti-Lopez, Francisco-Javier
Lopez-Martos, Ricardo
Ruiz-Canela-Mendez, Pablo
Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction
title Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction
title_full Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction
title_fullStr Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction
title_full_unstemmed Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction
title_short Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction
title_sort deep dry needling of trigger points located in the lateral pterygoid muscle: efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464920/
https://www.ncbi.nlm.nih.gov/pubmed/25662558
http://dx.doi.org/10.4317/medoral.20384
work_keys_str_mv AT gonzalezperezluismiguel deepdryneedlingoftriggerpointslocatedinthelateralpterygoidmuscleefficacyandsafetyoftreatmentformanagementofmyofascialpainandtemporomandibulardysfunction
AT infantecossiopedro deepdryneedlingoftriggerpointslocatedinthelateralpterygoidmuscleefficacyandsafetyoftreatmentformanagementofmyofascialpainandtemporomandibulardysfunction
AT granadosnunezmercedes deepdryneedlingoftriggerpointslocatedinthelateralpterygoidmuscleefficacyandsafetyoftreatmentformanagementofmyofascialpainandtemporomandibulardysfunction
AT urrestilopezfranciscojavier deepdryneedlingoftriggerpointslocatedinthelateralpterygoidmuscleefficacyandsafetyoftreatmentformanagementofmyofascialpainandtemporomandibulardysfunction
AT lopezmartosricardo deepdryneedlingoftriggerpointslocatedinthelateralpterygoidmuscleefficacyandsafetyoftreatmentformanagementofmyofascialpainandtemporomandibulardysfunction
AT ruizcanelamendezpablo deepdryneedlingoftriggerpointslocatedinthelateralpterygoidmuscleefficacyandsafetyoftreatmentformanagementofmyofascialpainandtemporomandibulardysfunction